08045800513
Send Inquiry
Send InquiryRabeprazole 20 mg & Itopride 150 mg (Sustained Release)
MOQ : 15-30 Boxes
Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) Specification
- Drug Type
- General Medicines
- Ingredients
- Rabeprazole 20 mg & Itopride 150 mg
- Physical Form
- Capsules
- Function
- Treat Gastric Issues
- Recommended For
- Moderate to Severe / Unresponsive GERD/Reflux Esophagitis
- Dosage
- 1 Capsule Daily
Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Supply Ability
- 100000 Boxes Per Month
- Delivery Time
- 4 Week
- Packaging Details
- Alu-Alu,10*10
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Rabeprazole 20 mg & Itopride 150 mg (Sustained Release)
Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) is a potent combination medicine designed to treat moderate to severe or unresponsive GERD (Gastroesophageal Reflux Disease) and reflux esophagitis. Available in capsule and tablet form, this dual-action formula targets gastric issues effectively. Rabeprazole 20 mg works as a proton pump inhibitor, reducing gastric acid production, while Itopride 150 mg improves gastrointestinal motility for enhanced digestive performance. Suitable for daily consumption, the recommended dosage is one capsule or tablet per day. Specifically formulated for individuals with persistent or chronic gastric conditions, this general medicine combination is highly effective for managing reflux and digestive discomfort. Ideal for export, manufacturing, and supply purposes, it is tailored for therapeutic use in clinical or commercial environments.
FAQs of Rabeprazole 20 mg & Itopride 150 mg (Sustained Release):
Q: What is the primary function of Rabeprazole 20 mg & Itopride 150 mg (Sustained Release)?
A: It is designed to treat moderate to severe or unresponsive GERD and reflux esophagitis.Q: How does this medicine work?
A: Rabeprazole reduces gastric acid production, while Itopride enhances gastrointestinal motility.Q: What is the recommended dosage for this product?
A: The recommended dosage is one capsule or tablet daily.Q: Who is this medicine recommended for?
A: It is recommended for individuals suffering from persistent gastric issues like GERD and reflux esophagitis.Q: What forms is this medicine available in?
A: It is available in capsule and tablet form.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Gastrointestinal Drugs Category
Ilaprazole-5 mg & 10mg
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Physical Form : Tablets
Drug Type : General Medicines
Recommended For : Ulcers,Gastric Issues
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Esomeprazole Magnesium 40 Mg
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Physical Form : Tablets
Drug Type : General Medicines
Recommended For : Gastric & Duodenal Ulcers, Stomal Ulcers, Gastric Mucosal Lesions, Preanesthesia medication
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Omeprazole Magnesium 20 Mg
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Physical Form : Tablets
Drug Type : General Medicines
Recommended For : Gastric Issues,Hyperacidity,GERD,IBS
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Pantoprazole 40 mg & Itopride 150 mg Tablet
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 500 Boxes
Physical Form : Tablets
Drug Type : Generic Drugs
Recommended For : Acidity with nausea
Ingredients : Pantoprazole & Domperidone
Contact Details
- Call us-9877184734, 6283732271, Plot No. 364, Industrial Area, Phase-1,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
